PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BMY vs. UNH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

BMY vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bristol-Myers Squibb Company (BMY) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
33.10%
15.39%
BMY
UNH

Returns By Period

In the year-to-date period, BMY achieves a 15.11% return, which is significantly higher than UNH's 13.82% return. Over the past 10 years, BMY has underperformed UNH with an annualized return of 2.74%, while UNH has yielded a comparatively higher 21.57% annualized return.


BMY

YTD

15.11%

1M

5.64%

6M

31.08%

1Y

16.17%

5Y (annualized)

3.51%

10Y (annualized)

2.74%

UNH

YTD

13.82%

1M

3.66%

6M

13.77%

1Y

11.38%

5Y (annualized)

18.83%

10Y (annualized)

21.57%

Fundamentals


BMYUNH
Market Cap$121.33B$575.41B
EPS-$3.53$15.38
PEG Ratio2.201.70
Total Revenue (TTM)$47.44B$392.72B
Gross Profit (TTM)$33.40B$88.91B
EBITDA (TTM)$18.32B$27.22B

Key characteristics


BMYUNH
Sharpe Ratio0.510.48
Sortino Ratio1.010.82
Omega Ratio1.121.11
Calmar Ratio0.300.58
Martin Ratio1.261.54
Ulcer Index11.52%7.60%
Daily Std Dev28.61%24.40%
Max Drawdown-70.62%-82.67%
Current Drawdown-24.61%-5.28%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.3

The correlation between BMY and UNH is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

BMY vs. UNH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BMY, currently valued at 0.51, compared to the broader market-4.00-2.000.002.004.000.510.48
The chart of Sortino ratio for BMY, currently valued at 1.01, compared to the broader market-4.00-2.000.002.004.001.010.82
The chart of Omega ratio for BMY, currently valued at 1.12, compared to the broader market0.501.001.502.001.121.11
The chart of Calmar ratio for BMY, currently valued at 0.30, compared to the broader market0.002.004.006.000.300.58
The chart of Martin ratio for BMY, currently valued at 1.26, compared to the broader market0.0010.0020.0030.001.261.54
BMY
UNH

The current BMY Sharpe Ratio is 0.51, which is comparable to the UNH Sharpe Ratio of 0.48. The chart below compares the historical Sharpe Ratios of BMY and UNH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio-2.00-1.50-1.00-0.500.000.501.001.50JuneJulyAugustSeptemberOctoberNovember
0.51
0.48
BMY
UNH

Dividends

BMY vs. UNH - Dividend Comparison

BMY's dividend yield for the trailing twelve months is around 4.27%, more than UNH's 1.34% yield.


TTM20232022202120202019201820172016201520142013
BMY
Bristol-Myers Squibb Company
4.27%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%2.46%3.31%
UNH
UnitedHealth Group Incorporated
1.34%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%1.39%1.40%

Drawdowns

BMY vs. UNH - Drawdown Comparison

The maximum BMY drawdown since its inception was -70.62%, smaller than the maximum UNH drawdown of -82.67%. Use the drawdown chart below to compare losses from any high point for BMY and UNH. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-24.61%
-5.28%
BMY
UNH

Volatility

BMY vs. UNH - Volatility Comparison

Bristol-Myers Squibb Company (BMY) has a higher volatility of 13.64% compared to UnitedHealth Group Incorporated (UNH) at 7.29%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JuneJulyAugustSeptemberOctoberNovember
13.64%
7.29%
BMY
UNH

Financials

BMY vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items